Spanish researchers develop five-strain Ebola vaccine

July 11, 2018
Credit: CC0 Public Domain

Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus in what would be a world first, Madrid's October 12 Hospital said Wednesday.

A prototype vaccine developed by pharmaceutical group Merck is already in use, but acts only against the most virulent, "Zaire" strain.

Despite not having market approval, Merck's rVSV-ZEBOV was administered to people in the Democratic Republic of Congo in May, with UN approval, in a bid to contain an outbreak of the same virus that killed more than 11,300 in three West African countries from 2013-2015, sparking international panic.

For several months, a team from the October 12 Hospital has been working with researchers at two other hospitals in the capital to examine and learn from blood samples taken from three people cured of Ebola in Spain.

Lead researcher Rafael Delgado told reporters the difficulty lay in the fact that the virus protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time.

That makes it tough for the body's immune system to fight the .

The three Spanish patients had produced "very effective" viral antibodies, though in a "small quantity" and only against the Zaire strain they were contaminated with.

Delgado, head of microbiology at the , said researchers are aiming to reproduce these antibodies on a larger scale, and in a way that would make them efficient against all five .

US medical giant Johnson & Johnson is separately developing an experimental vaccine against two Ebola .

Delgado said researchers hope to get results from mouse experiments within a year.

The Ebola epidemic caused alarm in Spain in 2014 when a nursing assistant, Teresa Romero, became the first person infected outside Africa.

She caught the disease while tending to a Spanish missionary repatriated from Sierra Leone, who died in Spain in September that year.

Explore further: New Ebola vaccine faces key test

Related Stories

New Ebola vaccine faces key test

May 18, 2018
The experimental Ebola vaccine dubbed rVSV-ZEBOV has shown promising signs that it can contain the spread of the prolific killer virus.

New breakthrough paving the way for universal Ebola therapeutic

May 7, 2018
A new collaborative study has identified and studied Ebola antibodies that could be used to design universal therapeutics that are effective against many different Ebola species. The findings were recently published in Nature ...

DR Congo reports four more Ebola cases

May 10, 2018
Four more cases of Ebola have been detected in northwest Democratic Republic of Congo, doctors said Thursday, two days after DRC reported a fresh outbreak of the disease.

DR Congo authorises trial of experimental Ebola vaccine

May 29, 2017
The Democratic Republic of Congo has approved using an experimental Ebola vaccine to combat an outbreak of the virus in the northeast, the government said Monday.

Ebola death toll close to 3,900: WHO

October 8, 2014
The death toll in the world's worst-ever Ebola epidemic has edged closer to 3,900, with the virus killing nearly half of the more than 8,000 people infected, UN figures showed Wednesday.

Spain officially free of Ebola (Update)

November 29, 2014
The World Health Organization on Tuesday declared Spain free of Ebola after going a month and a half with no new cases since an infected nurse successfully beat the disease.

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.